BWX Technologies (BWXT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 revenue rose 14% year-over-year to $672 million, driven by strong organic growth in Government Operations and stable Commercial Operations.
Adjusted EBITDA increased 19% to $127 million, and adjusted/non-GAAP EPS grew 24% to $0.83, reflecting margin expansion and lower corporate expenses.
Net income for Q3 2024 was $69.5 million, up from $60.3 million in Q3 2023; diluted GAAP EPS was $0.76.
Announced acquisition of AOT/A.O.T./Aerojet Ordinance Tennessee for approximately $98–$100 million, expected to close by year-end, expanding the special materials portfolio and defense sector capabilities.
Key contract wins include a pilot plant for domestic uranium enrichment, selection for HALEU deconversion services, and the Hanford Integrated Tank Disposition Contract.
Financial highlights
Q3 2024 revenue: $672 million, up from $590 million in Q3 2023; nine-month revenue increased 10.5% to $1.96 billion.
Adjusted EBITDA was $127 million (18.9% margin), up 19% year-over-year; operating income for Q3 was $96.6 million.
Adjusted/non-GAAP EPS was $0.83, up from $0.67 in Q3 2023; net income was $69.5 million.
Free cash flow for Q3 was negative at $7.7–$8 million, impacted by contract timing and higher capex; full-year guidance reaffirmed at $225–$250 million.
Capital expenditures for Q3 2024 were $40–$40.3 million; year-to-date capex reached $101 million.
Outlook and guidance
2024 adjusted/non-GAAP EPS guidance raised to about $3.20; consolidated revenue guidance increased to approximately $2.7 billion.
Free cash flow guidance reaffirmed at $225–$250 million; adjusted EBITDA guidance at ~$500 million.
2025 outlook projects mid- to high-single-digit growth in revenue, adjusted EBITDA, and EPS, with at least 10% free cash flow growth.
Government Operations expected to see mid-single-digit growth; Commercial Operations to grow high-single to low-double digits in 2024, with double-digit growth in power and medical segments in 2025.
48% of backlog revenue expected to be recognized by end of 2025.
Latest events from BWX Technologies
- 2026 outlook projects high-teens revenue growth and double-digit free cash flow, fueled by nuclear demand.BWXT
Investor presentation18 Mar 2026 - Virtual annual meeting to elect directors, approve pay, and ratify auditor on April 30, 2026.BWXT
Proxy Filing18 Mar 2026 - Record 2025 growth and strong 2026 outlook driven by nuclear demand and major contract wins.BWXT
Q4 202523 Feb 2026 - Q2 2024 delivered double-digit growth and a higher EPS outlook amid strong industry demand.BWXT
Q2 20242 Feb 2026 - $525M acquisition expands nuclear and isotope services, boosting global reach and workforce.BWXT
M&A Announcement10 Jan 2026 - Record revenue, backlog, and free cash flow drive strong 2025 growth outlook.BWXT
Q4 20247 Jan 2026 - Q1 2025 revenue up 13%, net income $75.5M, backlog $4.88B, 2025 outlook reaffirmed.BWXT
Q1 202525 Dec 2025 - 2025 proxy covers director elections, say-on-pay, officer liability, and auditor ratification.BWXT
Proxy Filing1 Dec 2025 - Board recommends all proposals, highlights strong governance, pay-for-performance, and ESG focus.BWXT
Proxy Filing1 Dec 2025